Guest guest Posted November 5, 2004 Report Posted November 5, 2004 THIS E-MAIL WAS RETURNED TO MRSJO- - <DrLance " SSRI-Crusaders Moderator " <SSRI-Crusaders-owner > Cc: <mrsjo-; <DrLance Friday, November 05, 2004 3:42 AM Drug, SSRI, Congitive & Memory Dysfunction,Iatrogenic-Ginkgo biloba,Cognitive & Vascular Benefits RE: Antidepressants Etiology of Cognitive & Memory Dysfunction Ginkgo Biloba Dear Mrs. Guest, After observing the severe mental & cognitive decline in my Mother being prescribed a variety of combinations of psychiatric drugs before her suicide I have an interest in finding remedies that can reverse the damage to mental function caused by selective serotonin reinuptake inhibitors (SSRI's). Thank you for this and other articles you have posted. Are you aware of any contraindications to ingesting Ginkgo biloba while a patient is consuming antidepressents or enduring the suffering struggle of the side effects of withdrawal? Are you aware of antidepressent dependent persons utilizing Ginko biloba to reverse the side effects of SSRI's? Thank you very much, Dr. Sandra Lance, D.C. Daughter of Alma Virginia Sanders Antidepressant Suicide Victim 800 309 6560 (5AM-11PM) __________________________ __________ Vascular & Cognitive Benefits of Ginkgo biloba JoAnn Guest Nov 04, 2004 21:02 PST ===================================================================== Vascular & Cognitive Benefits of Ginkgo biloba --- Extracts from the leaves of the ginkgo biloba tree have been used therapeutically in China for millennia. According to fossil records, the ginkgo tree has been around for over 200 million years and is one of the oldest still existing tree species on earth. Individual trees live up to 1,000 years. Ginkgo, like ginseng, is mentioned in the traditional Chinese pharmacopoeia. Ginkgo extracts are among the most widely studied and prescribed drugs in Europe to alleviate symptoms associated with a wide range of conditions. The main indications for these extracts are peripheral vascular disease and the therapy of age related cognitive decline. Ginkgo biloba is a mind booster underutilized by the medical profession. What's in Ginkgo biloba? Ginkgo contains many different substances but most of them fall into two main categories: Terpenoid lactones and Flavonoids. The most unique components of ginkgo extracts are the terpene trilactones which are structurally complex molecules. Terpene lactones give ginkgo a bitter and strong flavor. The most important terpenes are the ginkgolides and bilobides. Ginkgolides have not yet been found in any other living plant species. Other compounds in ginkgo biloba include proanthocyanidins, carboxylic acids and non-flavone glycosides Flavonoids are natural substances that are also found in fruits and vegetables. Flavonoids act as antioxidants, have an influence on the immune system, and interfere with tumor formation. Ginkgo contains many flavonoids but the most concentrated are kaempferol, quercetin, and isorhamnetin. Most ginkgo products on the market list a flavonoid concentration of 24%. You will often see 24% printed on packages or bottles of ginkgo. How Does Ginkgo Work? The active ingredients in gingko are believed to have their beneficial effects by acting as antioxidants, preventing red blood cells and platelets from aggregating to form clots, allowing more oxygen to reach neurons, and improving circulation in tiny blood vessels by inducing relaxation of the muscles surrounding blood vessels. Even circulation to the eyes improves when subjects are given ginkgo. Clinical Uses of ginkgo biloba The primary indications for ginkgo biloba are age related cognitive decline (ARCD) and Alzheimer's disease. Age related cognitive decline is a term that describes a collection of symptoms. These include difficulty in concentration and memory, absent-mindedness, confusion, lack of mental energy, and sometimes, depressive mood. Some of these symptoms may be associated with not enough blood reaching the brain, hence a potential justification for the use of gingko in lessening these symptoms. Ginkgo improves communication between nerve cells and enhances blood flow to the brain. It is licensed in Germany for the treatment of ARCD. Ginkgo may have promise in the treatment of Parkinson's disease and Alzheimer's when used together with other conventional medicines. A well publicized study- in the Journal of the American Medical Association indicated that 120 mg of ginkgo extract per day for one year was able to slightly improve cognitive performance in patients with Alzheimer's disease. Ginkgo may show a beneficial effect on attention, memory and functioning in Multiple Sclerosis patients. Patients with dementia are helped by ginkgo. It is unlikely that those with normal memory function will notice a significant effect from ginkgo. Ginkgo and Liver Ginkgo is able to protect the liver from damage since it has antioxidant properties, prevents *lipid* peroxidation and replenishes the glutathione level. The effects of ginkgo were comparable to that of silymarin. What Dosages of Ginkgo Are Best? The majority of the studies done thus far with ginkgo have used daily dosages of 120 to 160 mg (50:1 concentration, 24% flavonoids). Patients generally took 40 milligrams three to four times a day. Treatment may be needed for a few weeks before positive results can be fully appreciated. Most manufacturers have pills that contain 40 or 60 mg of ginkgo. You may wish to start with one 40 mg pill a day to see if there is any improvement in memory or thinking. Ginkgo is best taken early in the day, and no later than afternoon. Ginkgo has anti-platelet activity and hence may prolong the time it takes to form a blood clot (thrombus). However, a study published in April, 2003 indicates that Coenzyme Q10 and Ginkgo biloba do not influence the clinical effect of warfarin. An additional study did not find ginkgo to alter platelet " function " or coagulation time. Ginkgo Summary Ginkgo biloba appears to be useful in memory loss due to aging or Alzheimer's disease, but is probably of little benefit in the young who have normal brain function and memory. Middle aged and older individuals may find ginkgo to be helpful in sharpening the mind. For more details, see Mind Boosters book. Because of its antioxidant properties, it may be useful in individuals with cerebrovascular disease. Due to its blood thinning properties, a dose of 60 mg a day should not be exceeded on a daily, long-term basis unless a health care provider monitors you. Keep in mind that other nutrients and drugs have blood-thinning properties including coumadin, fish oils, and vinpocetine. Ginkgo Research Update Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability. Williams B.The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. Neurobiol Aging. 2004 Aug;25(7):955- 62. EGb 761 is a standardized extract from the Ginkgo biloba leaf and is purported to improve age-related memory impairment. The acute and chronic effect of Ginkgo biloba on synaptic transmission and plasticity in hippocampal slices from young adult (8-12 weeks) and aged (18-24 months) C57Bl/6 mice was tested because hippocampal plasticity is believed to be a key component of memory. Acutely applied Ginkgo biloba significantly increased neuronal excitability in slices from aged mice by reducing the population spike threshold and increased the early phase of long-term potentiation, though there was no effect in slices from young adults. In chronically treated mice fed for 30 days with an Ginkgo biloba-supplemented diet, Ginkgo biloba significantly increased the population spike threshold and long-term potentiation in slices from aged animals, but had no effect on slices from young adults. The rapid effects of Ginkgo biloba on plasticity indicate a direct interaction with the glutamatergic system and raise interesting implications with respect to a mechanism explaining its effect on cognitive enhancement in human subjects experiencing dementia. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies. Surgical Department, Hospital Porz/Rhein, Koln, Germany. Int J Clin Pharmacol Ther. 2004 Feb;42(2):63-72. OBJECTIVE: The present review gives an overview and evaluation of clinical studies proving the efficacy of Ginkgo biloba special extract EGb 761 in patients with PAOD. Relevant original papers and reports on this topic were identified by means of a literature search. Only randomized, double-blind, placebo-controlled clinical trials in patients with the indication peripheral arterial occlusive disease in stage II were included (only treatment with the oral form of Ginkgo biloba. For the selected studies the ratio theta of the walking distance between Ginkgo biloba and placebo was calculated and a test for relevant superiority of Ginkgo biloba was performed. In the majority of the studies, there was an advantage of Ginkgo biloba in the increase of pain-free walking distance compared to placebo. For 7 studies, the advantage was found to be statistically significant. Testing the relevant superiority showed a significant result in 6 of the selected studies. The pooled estimator of the ratio amounts to theta = 1.23 (95% CI: 1.16, 1.31) and demonstrates the efficacy of Ginkgo biloba over placebo as well. CONCLUSIONS: This review confirms the efficacy of Ginkgo biloba special extract EGb 761. It demonstrates not only the statistical significance of the difference of Ginkgo biloba with respect to placebo but also the clinical relevance for the treatment of patients with PAOD. The effect of ginkgo biloba on healthy elderly subjects Cieza A, Maier P, Poppel E. Fortschr Med Orig. 2003;121:5-10. BACKGROUND AND AIM: Over the past 25 years, numerous studies have confirmed the positive effect of the special ginkgo biloba extract EGb 761 on the mental ability and emotional well-being of patients with cognitive disorders of vascular genesis, and Alzheimer-type dementia. The following study investigated the short-term effect of the special ginkgo extract EGb 761 on the subjective emotional well- being of healthy elderly subjects. The study was designed as a randomized double-blind, monocenter study with parallel groups. It included 66 healthy subjects of both sexes aged between 50 and 65 with no age-related cognitive impairments. For a period of 4 weeks, 34 subjects received a daily dose of 240 mg ginkgo biloba , and 32 a placebo. RESULTS: The final examination revealed a statistically significant difference between the two groups for the VAS mental health and quality of life, as also for SIS Mood at the telephone interview in week 2. A comparison of baseline with the final examination within the groups showed a statistically significant improvement in the ginkgo biloba group for the variables: depression, fatigue, anger and SDS. For none of the variables investigated was a worsening observed in the ginkgo biloba group. CONCLUSIONS: The results suggest a positive effect of ginkgo biloba on the subjective emotional well-being of healthy elderly persons. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Kanowski S, Hoerr R. Psychiatrische Klinik und Poliklinik der Freien Universitat Berlin. Pharmacopsychiatry. 2003 Nov;36(6):297-303. In 1996, Kanowski et al. reported about the beneficial effects of ginkgo biloba special extract EGb 761 (240 mg/day) in outpatients with pre-senile and senile primary degenerative dementia of the Alzheimer type (DAT) and multi-infarct dementia of mild to moderate severity. After 24 weeks of treatment, the ITT analysis of the SKT and estimated ADAS-cog scores revealed a mean decrease in the total score by -2.1 points and -2.7 points, respectively, for the ginkgo biloba group, which indicates an improvement in cognitive function. On the contrary, the placebo group exhibited only a minimal change of -1.0 and -1.3 points, respectively. The Clinical Global Impression of Change (CGI, Item 2) favored the ginkgo biloba group with a mean difference of 0.4 points. Changes in the rating related to activities of daily living showed a favorable trend for ginkgo biloba. The results of this ITT analysis substantiate the outcomes previously obtained with a responder analysis of the per-protocol population and confirm that ginkgo biloba improves cognitive function in a clinically relevant manner in patients suffering from dementia. The therapeutic effect is in line with the outcome of another ginkgo biloba study conducted in the U.S. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Kyungpook National University, Taegu, South Korea. Hum Psychopharmacol. 2002 Aug;17(6):279-84. The aim of this study was to examine the effect of Ginkgo biloba on antidepressant-induced sexual dysfunction. The Ginkgo biloba (n=19) and the placebo groups (n=1 were divided; each to be administered with Ginkgo biloba and placebo respectively for 2 months by means of a randomized placebo-controlled, double-blind study. The results of this 2 month trial were: (1) there was no statistical significant difference from the placebo at weeks 2, 4 and 8 after medication; (2) in comparison with baseline, both the Ginkgo biloba group and the placebo group showed improvement in some part of the sexual function, which is suggestive of the importance of the placebo effect in assessing sexual function. This study did not replicate a prior positive finding supporting the use of Ginkgo biloba for antidepressant, especially SSRI, induced sexual dysfunction. Emails about Ginkgo I found that flax oil/fish oil along with vinpocentine in a small dosage and as well ginkgo, again in a small amounts eliminates the symptoms of Meniere's disease. I had all the symptoms for about a yr and a half. and finally i decided i would do something myself as i could not function and was offered no solution other than a lot of very expensive tests and procedures. " yep, you got a problem! " or expensive words to that effect. Q. Just thought I would mention that I have found ginkgo to be a wonderful supplement for the treatment of tinnitus (ringing in the ears) that was do to exposure to loud noise as a teenager. I would notice a significant improvement a day or two after taking the supplements (100mg 2x daily 24% standardization) and the ringing would gradually return after I would stop taking them. After using it on and off for several years the problem has faded into the background and they are now unnecessary. I observed no improvement in memory or concentration, though I might have been taking too little. A. Thanks for your feedback. Some studies do show ginkgo helpful for tinnitus, although my clinical experience with this herb for tinnitus has not shown a consistent beneficial response. http://www.raysahelian.com/ginkgo.html _________________ JoAnn Guest mrsjo- DietaryTi- www.geocities.com/mrsjoguest/Genes - " JoAnn Guest " <angelprincessjo Friday, November 05, 2004 12:08 AM Vascular & Cognitive Benefits of Ginkgo biloba > RE: Antidepressants Etiology of Cognitive & Memory Dysfunction Quote
Guest guest Posted November 6, 2004 Report Posted November 6, 2004 , <DrLance@j...> wrote: > > THIS E-MAIL WAS RETURNED TO MRSJO- > - > <DrLance@j...> > " SSRI-Crusaders Moderator " <SSRI-Crusaders- owner > > Cc: <mrsjo-; <DrLance@j...> > Friday, November 05, 2004 3:42 AM > Drug, SSRI, Congitive & Memory Dysfunction,Iatrogenic- Ginkgo > biloba,Cognitive & Vascular Benefits RE: Antidepressants Etiology of > Cognitive & Memory Dysfunction > Ginkgo Biloba > Dear Mrs. Guest, > After observing the severe mental & cognitive decline in my Mother being prescribed a variety of combinations of psychiatric drugs before her suicide I have an interest in finding remedies that can reverse the damage to mental function caused by selective serotonin reinuptake inhibitors (SSRI's). > Thank you for this and other articles you have posted. > Are you aware of any contraindications to ingesting > Ginkgo biloba while a patient is consuming antidepressents > or enduring the suffering struggle of the side effects of withdrawal? > Are you aware of antidepressent dependent persons utilizing > Ginko biloba to reverse the side effects of SSRI's? > Thank you very much, > Dr. Sandra Lance, D.C. > Daughter of Alma Virginia Sanders > Antidepressant Suicide Victim > 800 309 6560 > (5AM-11PM) > ________ Dear Dr. Lance, I am saddened to hear of your mother's suicide. These combinations (antidepressants) are indiscriminately prescribed without regard for the well being of the recipients. Whenever I am called upon to review some of the combinations I almost inevitably find that if the truth were known (per webmd & other sites), even orthodox medicine does not advise that they be taken in such extremely high dosages and dangerous combinations. Frequent misdiagnoses are `evil', but the fact remains that the atrocities continue and more victims are being led each day into a world from which they find it difficult to emerge. I have observed that those who are `under the influence' are very easy to `manipulate'. I find this very troubling. Evidently this is not a topic that is well researched, however I will post my current findings in the hopes that there will be more in the future! Dr. Murray finds that Gingko is effective with: Symptomatic relief of organic brain dysfunction GBE's antioxidant activity in the brain is of particular interest. The brain and central nervous system are particularly susceptible to free radical attack. Ginkgo increases blood flow to the brain and has excellent restorative effects on the nervous system. GBE has been shown to inhibit the reuptake of norepinephrine, serotonin, dopamine, and acetylcholine, important neurotransmitters in the brain. Ginkgo is of benefit for many of the presumed symptoms of aging such as: Anxiety and depression Memory impairment Poor concentration, decreased alertness Diminished intellectual capacity Supportive therapy consists of Ginkgo Phytosome (80 mg three times per day). Researchers began studying the antidepressive effects of Ginkgo biloba extract as a result of the improvement in mood noted by patients suffering from decreased blood flow to the brain (cerebrovascular insufficiency). Several studies were conducted to determine if Ginkgo biloba extract was, in fact, an antidepressant. In one of the more recent double-blind studies, 40 patients (ages ranged from 51 to 78 years) with depression who had not benefited fully from standard antidepressant drugs were given either 80 mg of Ginkgo biloba extract three times daily or a placebo. By the end of the 8th week study, the total score of the Hamilton Rating Scale for Depression in the Ginkgo biloba extract group had dropped from 14 to 4.5. In comparison, the placebo group dropped from 14 to only 13. This study indicated two things: (1) Ginkgo biloba extract can be used with standard antidepressants and/or St. John's wort extract and (2) it may enhance their effectiveness, particularly in patients over 50 years of age. I prefer the Ginkgo biloba extract bound to phosphatidylcholine (Ginkgo Phytosome) to un-bound ginkgo. Other studies on ginkgo have appeared in such diverse journals as Lancet, Audiology, and the Journal of Urology. Over 120,000 physicians worldwide write over ten million prescriptions for ginkgo each year, accounting for over five hundred million dollars in sales. Kind Regards, JoAnn JoAnn Guest mrsjo- DietaryTi- www.geocities.com/mrsjoguest/Genes Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.